CRISPR/Cas9 and Genome Editing in Drosophila  by Bassett, Andrew R. & Liu, Ji-Long
Available online at www.sciencedirect.comScienceDirect
Journal of Genetics and Genomics 41 (2014) 7e19
JGG
REVIEWCRISPR/Cas9 and Genome Editing in Drosophila
Andrew R. Bassett*, Ji-Long Liu*
MRC Functional Genomics Unit, University of Oxford, Department of Physiology, Anatomy and Genetics, South Parks Road, Oxford OX1 3QX, United Kingdom
Received 25 November 2013; revised 10 December 2013; accepted 11 December 2013
Available online 18 December 2013ABSTRACT
Recent advances in our ability to design DNA binding factors with specificity for desired sequences have resulted in a revolution in
genetic engineering, enabling directed changes to the genome to be made relatively easily. Traditional techniques for generating genetic
mutations in most organisms have relied on selection from large pools of randomly induced mutations for those of particular interest, or
time-consuming gene targeting by homologous recombination. Drosophila melanogaster has always been at the forefront of genetic
analysis, and application of these new genome editing techniques to this organism will revolutionise our approach to performing analysis
of gene function in the future. We discuss the recent techniques that apply the CRISPR/Cas9 system to Drosophila, highlight potential
uses for this technology and speculate upon the future of genome engineering in this model organism.
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The advent of genome sequencing and genome-wide
technologies for study of gene expression, polymorphism
and regulation has revolutionalised our ability to associate
genes with particular cellular functions or disease states
(McCarthy et al., 2008; Park, 2009). They have also allowed
us to make predictions about the function of a large proportion
of both coding and non-coding sequences (Roy et al., 2010;
Bernstein et al., 2012). Although various techniques such as
homologous gene targeting have allowed us to selectivelyAbbreviations: CRISPR, clustered regularly interspaced short palindromic
repeat; HRMA, high resolution melt analysis; PAM, protospacer adjacent
motif; crRNA, CRISPR RNA; tracrRNA, trans-acting crRNA; Cas, CRISPR-
associated; gRNA, guide RNA; sgRNA, single guide RNA.
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Open access under CC BY license.mutagenise or alter gene function in a desired manner (Rong
and Golic, 2000), the difficulty of applying these techniques
on a large scale has restricted our ability to test hypotheses
generated from such genome-wide analyses.Genome editing systemsGenome editing technologies have been developed over the
past decade that allow us to selectively mutagenise specific
regions of the genome, and allow sophisticated and detailed
mechanistic studies to be performed in a variety of organisms
including Drosophila (Beumer et al., 2006, 2008; Liu et al.,
2012). These technologies rely on specific DNA binding fac-
tors that can be used to target various functional domains to
defined regions of the genome. Most experiments have used
these reagents to generate a double strand break (DSB) in the
DNA at the target site, that can then be repaired by non-
homologous end joining (NHEJ) or homologous recombina-
tion (HR) (Bibikova et al., 2002). NHEJ is somewhat error-
prone, and can result in the deletion or insertion of a few
bases at the cut site, resulting in mutation of the DNA
(Bibikova et al., 2002). HR normally results in precise repairemy of Sciences, and Genetics Society of China.
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mologous template is supplied, this may be used to introduce
defined changes in the underlying DNA (Bibikova et al., 2003;
Beumer et al., 2006, 2008).
The discovery that zinc finger DNA binding domains had a
modular structure, each binding to three bases within the DNA
provided the opportunity to select these proteins in vitro to bind
to desired sequences within the genome (Choo and Klug,
1994a, 1994b). These reagents, when fused to a non-specific
endonuclease domain, have been used successfully in various
organisms, including flies, to induce DSBs at desired sites,
resulting in targeted mutagenesis (Bibikova et al., 2002, 2003;
Beumer et al., 2006, 2008). Direct injection into Drosophila
embryos was shown to be able to introduce small insertions or
deletions (indels). Upon coinjection of a homologous template
DNA, this also allowed relatively efficient gene targeting
(Beumer et al., 2008, 2013), which until this point was a time
consuming and labour intensive process in Drosophila (Rong
and Golic, 2000). However, the fact that the binding prefer-
ence of each zinc finger depends on its context within the
polypeptide (Del Rio et al., 1993; Bulyk et al., 2002) makes
prediction of the binding sites of multimeric zinc fingers diffi-
cult, hindering a more general application of this technique.
A second class of highly modular DNA binding proteins
termed transcription activator like effectors (TALEs) were
discovered in the plant pathogen Xanthomonas (Bonas et al.,
1989; Boch et al., 2009; Moscou and Bogdanove, 2009). They
are made of 34 amino acid repeating units, each binding to a
single base of DNA in a highly predictable manner, dependent
on the identity of two amino acids (the repeat variable diresidue
or RVD) within each unit (Boch et al., 2009; Moscou and
Bogdanove, 2009). DNA binding of each unit was essentially
independent of its context, and the number of monomer units
can be adjusted to determine the length of the DNA binding site
(Cermak et al., 2011; Li et al., 2011). This provides exquisite
specificity in DNA binding, but assembly of these repetitive
multimers requires complex systems of cloning (Cermak et al.,
2011; Reyon et al., 2012; Sanjana et al., 2012), and the relatively
large size of the resulting polypeptides makes their manipula-
tion and expression somewhat problematic in some contexts.CRISPR/Cas9The clustered regularly interspaced short palindromic
repeat (CRISPR/Cas9) system acts as a bacterial defense
system against invading viruses and plasmids in many
different bacterial species (Fig. 1 and Table S1) (Ishino et al.,
1987; Jansen et al., 2002; Barrangou et al., 2007; Garneau
et al., 2010). The best studied system is that from Strepto-
coccus pyogenes. Here, the Cas9 endonuclease is targeted to
sequences from the invading pathogen by a crRNA (CRISPR
RNA), that provides specificity to the endonuclease by base
pairing with a 20 nt complimentary sequence within the DNA
(Brouns et al., 2008; Gasiunas et al., 2012; Jinek et al., 2012).
Endogenously, a further component, known as the tracrRNA
(trans-acting crRNA) forms a complex with the crRNA and
targets its incorporation into the Cas9 complex. Recently, thissystem has been shown to work in many other organisms,
including mammalian (Cong et al., 2013; Jinek et al., 2013;
Mali et al., 2013b; Wang et al., 2013), insect (Bassett et al.,
2013, 2014; Gratz et al., 2013; Kondo and Ueda, 2013; Ren
et al., 2013; Sebo et al., 2013; Yu et al., 2013), plant (Shan
et al., 2013) and fungal (DiCarlo et al., 2013) cells. Fusion
of the crRNA and tracrRNA into a w100 nt synthetic single
guide or chimeric RNA (sgRNA or chiRNA) has further
simplified this system, which then only requires two compo-
nents to be expressed (Dahlem et al., 2012; Jinek et al., 2012;
Cong et al., 2013; Mali et al., 2013b) (Fig. 2). The specificity
is determined by a 20 nt sequence at the 50 end of the sgRNA,
which can be altered to match any desired sequence in the
DNA. The only limitation upon this targeting is that the 20 nt
guide sequence has to be followed by a protospacer adjacent
motif (PAM) of NGG in the DNA in order for efficient
cleavage to occur (Fig. 2). This sequence should occur on
average every 8 bases in the DNA, but recent reports have
suggested that this requirement may be relaxed to include
NAG sequences (Mali et al., 2013a), increasing the number of
potential target sites still further. CRISPR systems from other
bacterial species have different PAM requirements, for
example CWT and GAA (Mojica et al., 2009; Esvelt et al.,
2013) and this suggests that it will be possible to engineer
Cas proteins to bind to essentially any sequence in the future.
DROSOPHILA CRISPR SYSTEMS
Several groups have used the CRISPR/Cas9 system to
induce targeted mutations in Drosophila (Bassett et al., 2013;
Gratz et al., 2013; Kondo and Ueda, 2013; Ren et al., 2013;
Sebo et al., 2013; Yu et al., 2013), but differ in their
approach to supplying the Cas9 protein and sgRNA compo-
nents of the system (Tables 1 and 2).
The first description of mutagenesis with CRISPR/Cas9
involved coinjection of two plasmids into syncytial blastoderm
stage Drosophila embryos (Gratz et al., 2013). One plasmid
expresses the Cas9 gene under the Hsp70 promoter, and the
second produces the sgRNA, driven by a pol III promoter from
the U6 gene. This was tested at the yellow gene, and resulted
in mutagenesis of the gene that was capable of being trans-
mitted to subsequent generations. The efficiency of mutagen-
esis due to inefficient NHEJ was fairly low, with 5.9% of the
injected flies giving rise to at least one mutant offspring (Table
1) (Gratz et al., 2013). However, the authors further demon-
strated that if two sgRNAs are supplied, targeting either end of
the yellow gene, this can result in deletion of the intervening
sequence, and that integration of short sequences at the
cleavage site is possible by coinjection with a short single
stranded oligonucleotide donor sequence (Gratz et al., 2013).
A second technique that has been applied by two groups
independently involves coinjection of in vitro transcribed Cas9
mRNA and sgRNA into early stage embryos, and achieves
much higher mutagenesis rates due to inefficient NHEJ
(Bassett et al., 2013; Yu et al., 2013). Bassett et al. showed that
up to 88% of injected flies gave rise to mosaic expression of
the yellow gene implying that this technique is highly efficient.
Fig. 1. Timeline of CRISPR research e from exploration to explosion.
Four milestone studies are highlighted in red boxes. See Table S1 for a more detailed timeline with references. Background drawings courtesy of Aaron H. Tan.
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Table 1
Comparison of CRISPR genome engineering studies in Drosophila
Reference Gratz et al., 2013 Bassett et al., 2013 Yu et al., 2013 Kondo and Ueda, 2013 Sebo et al., 2013 Ren et al., 2013
Cas9 promoter hsp70 T7 Sp6 nos vasa nos
Delivery DNA injection mRNA injection mRNA injection Transgenic Transgenic Transgenic
sgRNA promoter U6 T7 T7 U6 U6 U6a, U6b, nos-mini
Delivery DNA injection sgRNA injection sgRNA injection Transgenic DNA injection DNA injection
Gene targeted yellow yellow, white yellow, K81,
CG3708,
CG9652, kl-3,
light, RpL15
white, neuropeptide
genes (Ast, capa, Ccap,
Crz, Eh, Mip, npf ),
mir-219, mir-315
EGFP, mRFP white
Mutant detection Body colour,
surveyor
assay, DNA
sequencing
Body colour,
eye colour,
DNA sequencing,
HRMA
Body colour, DNA
sequencing
Eye colour,
T7 endonuclease,
DNA sequencing
Fluorescence
in the eye
Eye colour, HRMA,
DNA sequencing
G0 adult fertility (%)
a nd 37.5e73.1 21.6e94.4 N/A 32e55 29.4e92.9
Mosaic G0 (%)
b 6e66 4e88 35.7e80 N/A 0g 0g
Germline mutants
(among fertile flies) (%)c
5.9e20.7 0e79 35.7e100 0e100 35e71 0e100
Germline mutants
(of injected flies) (%)d
nd 0e58 nd N/A N/A 0e81.2
G1 mutant rate per fly (%)
e nd 0e88.5 N/A N/A 0e100 0e100
G1 mutant overall (%)
f 0.25e1.37 0e34.5 2.1e98.9 0e99.4 7.7e24.7 0e74.2
Off-target detection method nd HRMA nd nd nd HRMA, DNA
sequencing
Off-target detected nd No nd nd nd No
Homologous recombination Oligonucleotide nd nd nd nd nd
Long deletions Yes No No Yes No Yes
a Number of fertile flies as a proportion of the surviving injected flies; b Percentage of flies that exhibit mosaic expression in the injected generation, either
visibly in males or detected using HRMA (high resolution melt analysis); c Proportion of fertile flies giving rise to at least one mutant offspring; d Propor-
tion of injected flies giving rise to at least one mutant offspring; e For individual flies, the range of the percentage of mutant offspring; f Total number of
mutant G1 offspring as a percentage of the total offspring;
g No mosaic expression would be expected, due to germline expression of Cas9; N/A, not applicable
to this technique; nd, not determined in this study.
Fig. 2. Two-component CRISPR/Cas9 system for genome editing.
The Cas9 protein (blue oval) is recruited to a target site in the DNA by a 20 nt complimentary sequence in the synthetic single guide RNA (sgRNA, dark blue).
Cleavage requires a protospacer adjacent motif (PAM (NGG), red) in the DNA, which does not appear in the sgRNA. A double strand break is made 3 nt from the
PAM sequence on both strands of the DNA (cleavage site, black triangles).
10 A.R. Bassett, J.-L. Liu / Journal of Genetics and Genomics 41 (2014) 7e19
Table 2
Web resources for CRISPR/Cas study
Name Link Brief description Reference
Drosophila CRISPR web resources
OxfCRISPR (Liu Lab) http://www.oxfcrispr.org/ Oxford Fly CRISPR Resources Bassett et al., 2013
CRISPRflydesign (Bullock Lab) http://www.crisprflydesign.org/ Offers Cas9 transgenic stocks n/a
DRSC CRISPR finder (Perrimon Lab) http://www.flyrnai.org/crispr/ A web tool to identify CRISPRs for fly study Ren et al., 2013
FlyCas9 (Ueda Lab) http://www.shigen.nig.ac.jp/fly/nigfly/cas9/index.jsp Provides reagents, protocols and online tools for
genome engineering by the designer nuclease Cas9
in Drosophila
Kondo and Ueda, 2013
flyCRISPR (O’Connor-Giles Lab,
Wildonger Lab and Harrison Lab)
http://flycrispr.molbio.wisc.edu/ Fly CRISPR resources Gratz et al., 2013
flyCRISPR discussion group https://groups.google.com/forum/#!forum/flycrispr-discussion-group A forum for sharing developments, insights, ideas
and asking questions related to fly CRISPRs
Gratz et al., 2013
Fly target sites (Zhang Lab) http://www.genome-engineering.org/crispr/?page_id¼41 For application of Cas9 for site-specific genome
editing in eukaryotic cells and organisms
Hsu et al., 2013
General CRISPR resources
Addgene CRISPR plasmids http://www.addgene.org/CRISPR/ A collection of CRISPR plasmids and reagents n/a
Crass: The CRISPR Assembler http://ctskennerton.github.io/crass/ A program that searches through raw metagenomic
reads for CRISPRs
Skennerton et al., 2013
CRISPI http://crispi.genouest.org/ A web interface with graphical tools and functions
allows users to find CRISPR in personal sequences.
Rousseau et al., 2009
CRISPR Discussion Forum https://groups.google.com/forum/#!forum/crispr A forum to discuss Genome Engineering using
CRISPR/Cas systems
Cong et al., 2013
CRISPRmap http://rna.informatik.uni-freiburg.de/CRISPRmap Web server provides an automated assignment of newly
sequenced CRISPRs to standard classification system
Lange et al., 2013
CRISPRs web server http://crispr.u-psud.fr/ A gateway to publicly accessible CRISPRs database
and software including CRISPRFinder, CRISPRdb
and CRISPRcompar
Grissa et al., 2007a,
2007b, 2008
CRISPRTarget http://bioanalysis.otago.ac.nz/CRISPRTarget Predicts the most likely targets of CRISPR RNAs Biswas et al., 2013
E-CRISP http://www.e-crisp.org/ A software tool to design and evaluate CRISPR target sites n/a
Goldstein Lab CRISPR http://wormcas9hr.weebly.com/ A genome engineering resource for the Caenorhabditis
elegans research community
Dickinson et al., 2013
Joung Lab CRISPR http://www.crispr-cas.org/ A genome engineering resource for zebrafish research
community
Hwang et al., 2013
Zhang Lab Genome Engineering http://www.genome-engineering.org/ CRISPR genome engineering resources website Cong et al., 2013
ZiFiT target design tool http://zifit.partners.org/ZiFiT/ Identifies potential target sites in DNA sequences Sander et al., 2007, 2010
n/a, not available.
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at the yellow gene, but also showed successful mutagenesis at
six other target loci spread throughout the genome, demon-
strating the general applicability of this approach. The dif-
ference in efficiency between plasmid and mRNA injection
techniques may be explained by the expression levels of the
Cas9 protein and sgRNA, or by the timing of expression
relative to the specification of germ cells in the embryo.
A third system has also been developed whereby two
transgenic flies are produced, one expressing Cas9 in the
germline under the nanos promoter, and a second with ubiq-
uitous expression of the sgRNA again driven by the U6 pro-
moter (Kondo and Ueda, 2013). When these two flies are
crossed together, highly efficient mutagenesis can be achieved,
giving rise to up to more than 90% of flies with at least one
mutant offspring (Table 1), and allowing longer deletions of up
to 1.6 kb to be made efficiently by coexpression of two
sgRNAs. Although efficient, this requires the time consuming
step of producing a new transgenic fly for each sgRNA
required, and removal of the Cas9 and sgRNA transgenes after
mutant generation. However, this technique will have advan-
tages in certain applications, since it is more reproducible than
the techniques involving embryo injection.
The final technique uses injection of plasmids encoding the
sgRNA into transgenic lines in which Cas9 is expressed spe-
cifically in the germline under the vasa (Sebo et al., 2013) or
nanos (Ren et al., 2013) promoters. These techniques avoid
potentially problematic somatic mutagenesis by limiting Cas9Fig. 3. Double strand break repair can be used to target defined genomic changes
The double strand break (DSB) induced by the Cas9/sgRNA complex can be repaire
This can result in small insertions or deletions at the target site (left), deletions of l
with a desired template (right). This can be used to alter the genome in a varietyexpression to the germline cells. Sebo et al. (2013) demon-
strated high rates of mutagenesis in the G1 offspring derived
from flies injected with plasmids encoding sgRNAs, but a
significant proportion of the injected flies were infertile. By
using the nanos promoter to drive Cas9 expression, Ren et al.
(2013) achieved higher rates of fertility, and generated high
rates of mutagenesis in G1 offspring (Table 1).
In addition to the injection of vectors expressing guide
RNAs (gRNAs), the production of fly lines that express Cas9
either ubiquitously or in the germline will also allow direct
injection of in vitro transcribed sgRNA into these embryos.
However, the relative efficiency of this technique has not been
established.
Recently, expression vectors for Cas9 expression in
Drosophila cell lines have also been described. The Actin5c and
U6 promoters were use to drive expression of the Cas9 and
sgRNA components, respectively. This results in highly efficient
mutagenesis inmore than80%cells due to the indels generated by
inefficient NHEJ. The authors also demonstrated that homolo-
gous integration is possible using short oligonucleotide donors to
insert small sequences, or longer homology arms to insert a 1.8 kb
cassette at up to 4% efficiency (Bassett et al., 2014).
USES OF CAS9 INDUCED DSBS IN GENOME
ENGINEERING
The majority of applications of CRISPR/Cas9 in genome
engineering use its ability to introduce DSBs at specific sites.
d by non-homologous end joining (NHEJ) or homologous recombination (HR).
arger genomic regions when two cuts are made (middle) or homologous repair
of different ways (bottom).
Fig. 4. Uses of genome editing within protein coding genes.
NHEJ repair (top) of Cas9-induced DSBs can be used to remove functional elements or disrupt genes in a variety of different ways. HR repair (bottom) can be used
to insert or replace sequences present within the gene for a variety of different uses. Exons are indicated as boxes, with coding sequence (CDS) in dark blue and
untranslated region (UTR) in grey. Enhancers are also indicated in light blue.
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or HR, and both repair mechanisms can be used to generate
mutations and manipulate the genome in a defined manner
(Figs. 3 and 4).NHEJMistakes during the NHEJ repair process often result in
small indels, and these can be useful in mutagenesis by
shifting reading frame of protein coding genes, resulting in
null mutations or truncations of the protein sequence. It is also
possible to use the indels generated to disrupt other small
functional sites within the genome such as transcription factor
binding sites, miRNA (microRNA) genes, splice donor or
acceptor sites and critical amino acids within protein coding
sequence (Fig. 4). These kinds of mutation can be used to
define regulatory regions, investigate miRNA function, or
force different splicing patterns to occur as well as generating
mutations within protein coding genes.
Pairs of nucleases can also be used to trigger deletion or
inversion of intervening sequences (Gupta et al., 2013; Xiao
et al., 2013) (Fig. 3). This can be useful to make defined de-
ficiencies or remove larger functional regions, such as protein
domains, non-coding RNA genes or larger regulatory elements
from the genome, or investigate the effects of larger chro-
mosomal rearrangements upon the function of the organism.Uses of NHEJ-mediated mutationThe development of CRISPR/Cas9 for genome engineer-
ing in Drosophila can be used to generate mutations inprotein coding genes, especially those that have been re-
fractory to current technologies such as P-element muta-
genesis. Despite the large number of more than 30,000
transposon insertions and other mutants generated in this
organism, only 40%e50% of annotated protein coding genes
contain an insertion, and although many of these have
orthologs in other species, their function remains unknown
(Bellen et al., 2004, 2011).
Only 20% of the Drosophila genome codes for proteins (Lin
et al., 2007), yet around 50% of the sequence displays evolu-
tionary conservation (Meader et al., 2010), suggesting that it
may be functional. Targeted mutagenesis can also be applied to
study of the regulatory or other functional elements present
within this sequence, such as transcription factor binding sites,
non-coding RNAs and other non-coding elements.
The ability to inject into essentially any genetic background
(Bassett et al., 2013; Yu et al., 2013) will also allow the
compounding of multiple mutations, especially those that are
tightly linked genetically. This will enable studies of redun-
dancy amongst members of a protein family, or epistasis or
genetic interactions between tightly linked genes. We have
also shown that coinjection of two sgRNAs can result in
simultaneous mutation of two target genes, making such an-
alyses even easier to achieve (Fig. 5). Being able to create
mutants in a defined genetic background will also benefit
studies of more subtle phenotypes such as behaviour, that are
highly dependent on the background used, relieving the need
for time consuming backcrossing. The fact that only two
components need to be supplied, and that RNA injection
techniques can be applied to multiple Drosophila species will
also make it useful for evolutionary and developmental studies
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changes between different species.
The high efficiency of homozygous mutant generation by
CRISPR/Cas9 systems will also make it possible to perform
mosaic analysis either by embryo injection of RNA (Bassett
et al., 2013; Ren et al., 2013; Sebo et al., 2013; Yu et al.,
2013) or crosses between Cas9 and sgRNA transgenes
(Kondo and Ueda, 2013). Homozygous mutant patches can be
marked with an antibody to the protein of interest, and used to
study phenotypes in an otherwise wild type background. It
may also be possible to generate tissue, cell and develop-
mental stage-specific knockouts by expression of the Cas9
protein in specific patterns using the UASeGAL4 system, and
subsequent crossing these flies to flies expressing the sgRNA
of choice. This kind of system may be useful to investigate
essential genes whose knockout results in early lethality.HRCreation of a DSB increases the rate of homologous repair at
that site by several orders of magnitude (Gloor et al., 1991;
Choulika et al., 1995; Smih et al., 1995), and this enables
gene targeting to produce defined genetic changes much more
rapidly and quickly than with classical techniques (Rong and
Golic, 2000) (Fig. 3). This relies on supplying a large excess
of a homologous repair template with the desired changes
(Beumer et al., 2008, 2013). The donor DNA (ssDNA) can take
two forms: single stranded DNA (ssDNA) oligonucleotidesFig. 5. Genetic screening with CRISPR/Cas9 can be performed on individual case
CRISPR/Cas9 nucleases can be used individually in a one-by-one manner (left) to d
also be combined to disrupt more than one gene simultaneously as indicated by the
be pooled (right) and transformed into cells or injected into flies. After selection or s
of the genomic regions targeted by the sgRNAs.synthesised up to 200 nt in length and used to integrate short
sequences, or longer double stranded DNA (dsDNA) constructs
containing hundreds to thousands of nucleotides of homologous
sequence on either side of the DSB site (Beumer et al., 2013).
The latter are capable of integrating longer sequences at higher
efficiency. The majority of repair events in fly cells occur by
NHEJ, but repair can be biased towards HR by using a mutation
in an essential component of the NHEJ pathway, DNA ligase 4
(lig4) (Beumer et al., 2008, 2013; Bassett et al., 2014). This
reduces the number of non-homologous integrants significantly,
greatly improving the efficiency of homologous gene targeting.Integration of short sequences with ssDNA
oligonucleotidesIntegration of ssDNA oligonucleotides allows sequences
such as epitope tags to be integrated into protein coding genes
for detection of endogenous proteins, and defined mutations to
be generated (Fig. 4). This can be useful to generate disease
models, investigate the function of specific amino acids in
proteins or recapitulate polymorphisms in coding or non-
coding regions for studies of evolution.
Site-specific recombinase sites such as the widely used attP
sites (Groth et al., 2004) can also be integrated to allow sub-
sequent modifications at the same position to be easily ach-
ieved. This technique can also be combined with two sgRNAs
to remove a genomic region and replace it with a site-specific
recombinase site (Gratz et al., 2013). This allows subsequents or in a pooled manner.
isrupt the function of a gene and measure phenotypes in flies or cells. They can
mosaic yellow and white expression in the indicated fly. The nucleases can also
creening for a phenotype of interest, mutations can be identified by sequencing
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perform detailed investigations of its function. Other recom-
binase sites such as flippase recognition target (FRT) sites
(Golic and Lindquist, 1989) could be introduced flanking the
region of interest to allow tissue specific or clonal deletion of
genomic regions (Fig. 4).Integration of other sequences with long dsDNA donorsLonger dsDNA homology arms can also be used in the
targeting vector to integrate longer sequences at higher effi-
ciency than short oligonucleotides (Beumer et al., 2013). This
allows use of a marker gene to allow simple selection for
homologous integrants, which is particularly advantageous as
the efficiency of this process is still relatively low. Studies in
both flies (Beumer et al., 2013) and S2 cells (Bassett et al.,
2014) have suggested that 1 kb of homology at either side
of the integration site directs efficient homologous integration,
which makes construction of the targeting constructs simple,
and detection of integration possible by PCR. As well as
integration of a positive marker for integration, homologous
targeting in Drosophila has been optimised by incorporation of
negative selectable markers such as UAS-rpr outside of the
homology arm to enable selection against non-homologous
integrations (Huang et al., 2008; Baena-Lopez et al., 2013).
These techniques could be applied to improve efficiency still
further.
Larger homology arms enable integration of longer fea-
tures, for example fluorescent proteins such as GFP to visu-
alise expression of proteins, GAL4 as a transcriptional reporter
to analyse expression patterns of transcripts or affinity tags for
efficient protein purification (Fig. 4). Tagging at the endoge-
nous locus would ensure that such proteins would be subject to
the same transcriptional and post-transcriptional controls as
the endogenous gene, and one would be sure of their func-
tionality and expression level.
TARGETED GENETIC SCREENING
The simplicity at which sgRNAs can be made also offers
the opportunity to create genome-wide libraries targeting
every protein coding gene. This would provide a resource of
specific mutagens that target only the regions of interest, rather
than the random mutagens currently used such as ethyl
methanesulfonate (EMS), X-rays or P-elements. This provides
a revolutionary approach to genetic screening, both in cell
culture and in the context of a whole organism.
Due to the ease at which the mutations can be identified,
this can be performed on a pooled collection of sgRNAs as
well as using a one-by-one targeted approach (Fig. 5). This
offers an alternative to the genome-wide RNAi libraries
currently available in cells and that are being generated in flies
(Flockhart et al., 2006; Flockhart et al., 2012). These are only
able to provide a partial and post-transcriptional loss of
function rather than genetic knockouts.
Cell-based systems can be used to screen for mutations
involved in selectable cellular phenotypes, but perhaps one ofthe most exciting possibilities would apply genome wide li-
braries of sgRNAs in the context of the whole organism
(Shalem et al., 2014; Wang et al., 2014). This would enable
screens for phenotypes resulting from gene knockout or to
perform genetic modifier screening far more efficiently. This
would allow rigorous genetic screens that knock out the
function of every protein coding gene in a defined manner. It
would also be possible to perform semi-targeted mutagenesis
by selecting subsets of sgRNAs based on expression patterns
in the tissue of interest, subcellular distributions or involve-
ment in particular biological processes.
EXTENDED USES OF THE CAS9 SYSTEM
Recently, there have been many developments of the Cas9
system, other than the introduction of DSBs. These use a
mutant Cas9 protein that is catalytically inactive and unable to
cleave the DNA, resulting in a sequence specific DNA binding
factor that can be targeted to virtually any genomic region by
coexpression with a sgRNA (Qi et al., 2013).
The simplest use of this system is to sterically interfere with
the process of transcription by targeting the Cas9esgRNA
complex to the middle of a transcribed region, known as
CRISPRi (Qi et al., 2013) (Fig. 6). This has been demonstrated
to interfere with the progress of RNA polymerase and reduce
transcription levels in both bacterial and mammalian cells, and
could be applied to any other system.
Furthermore, the Cas9 protein can be fused to other pro-
teins of interest in order to target them to specific sites within
the DNA. These could be fluorescent proteins to tag specific
DNA sequences for live imaging, or affinity tags for purifi-
cation of specific regions of chromatin. Transcriptional acti-
vation and repression has been demonstrated by fusion of Cas9
to multiple copies of the strong activation domain (VP64)
(Cheng et al., 2013; Farzadfard et al., 2013; Mali et al., 2013a;
Perez-Pinera et al., 2013) or Kru¨ppel-associated box (KRAB)
repression domain (Farzadfard et al., 2013; Gilbert et al.,
2013) in human cells, and this could be used to regulate
gene expression without introduction of exogenous sequences.
It would also be possible to recruit chromatin modifying
complexes, enabling addition or removal of post-
transcriptional modifications of histones and DNA or ATP-
dependent chromatin remodelling enzymes to alter nucleo-
some positions or to incorporate specific histone variants. This
will enable study of directed changes to epigenetic states to
investigate their roles in vivo.
Dimerisation domains could also be fused to Cas9, and
pairs of Cas9 proteins targeted to discrete regions of the
genome could force looping of the intervening DNA. This can
be used to reorganise the topology of the underlying chromatin
and study its effects on gene expression.
It has also been demonstrated that the sgRNA can be
extended at its 30 end, providing an opportunity to use the
CRISPR/Cas9 system to recruit RNA molecules to sites within
the DNA. Recent studies have postulated that some non-
coding RNAs can recruit protein complexes to specific re-
gions of the genome (Khalil et al., 2009; Zhao et al., 2010;
Fig. 6. Alternative uses of nuclease-deficient Cas9 protein.
Nuclease deficient Cas9 protein (Cas9 mut) can be used for multiple other functions including regulation of transcription by interference with RNA polymerase
(CRISPRi) or fusion to transcriptional activation (VP64) or transcriptional repression (KRAB) domains. Other functions include DNA tagging with GFP, chromatin
purification using an affinity tag, RNA recruitment by fusion to the sgRNA, or altering DNA topology by using dimerisation domains (DNA looping). Chromatin
modification with histone methyltransferase (HMT), acetyl-transferase (HAT), demethylase (KDM) or deacetylase (HDAC) can also be targeted by fusion to the
appropriate domains.
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can be used to test the effect of artificial recruitment of RNAs
to specific points within the genome to test such hypotheses.
Given the exquisite specificity of Cas protein binding to the
structure present within the gRNA, this may be fused to other
RNAs as an affinity tag, and used to visualise or purify a RNA
by virtue of its binding to the Cas protein (Lee et al., 2013).
LIMITATIONS OF THE CRISPR/CAS9 SYSTEM
A limitation of the CRISPR/Cas9 system is its relatively
low targeting specificity, which is determined by a 20 nt
recognition site and the requirement for the neighbouring
PAM sequence (NGG) (Wei et al., 2013). This is further
confounded by the fact that several mismatches within the
target sequence can be tolerated, whilst still directing efficient
cleavage (Fu et al., 2013; Mali et al., 2013a). However, due to
its relatively small genome size, this is less of a problem in
Drosophila than in other systems, and sequences can be
carefully chosen that minimise such off-target effects. Several
web-based algorithms to perform such analyses have recently
been described (Ren et al., 2013) (Table 2). The short gener-
ation time of Drosophila also allows such off-target mutationsto be removed relatively simply by backcrossing if specific
target sites are not available. It would also be possible to use
the “double-nick” approach to improve specificity. This uses a
mutated Cas9 protein that is only able to make single strand
nicks in the DNA. By judicious use of two sgRNAs that target
nearby sequences, this doubles the sequence specificity, and
additionally requires correct spacing between the two target
sequences (Mali et al., 2013a; Ran et al., 2013).
Another issue with sgRNA design is that the efficiency of
cleavage varies considerably at different target sites. This
could be due to many reasons such as secondary structures
within the sgRNA, thermodynamic stability of the sgRNA-
DNA duplex or accessibility of the target sequence within
the context of chromatin. Rigorous studies of such effects have
not yet been performed, and it is therefore important to design
multiple sgRNAs for each desired target to maximise chances
of successful mutagenesis.
Recent observations have also suggested that over-
expression of Cas9 alone with the actineGAL4 driver can
result in toxicity. This suggests that even in the absence of a
sgRNA, there may be a degree of non-specific off-target
mutagenesis, which should be borne in mind when analysing
Cas9-induced mutations. As the technique becomes more
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stood, allowing us to minimise their effects. Forums for dis-
tribution of such information are now available (Table 2), and
will no doubt enhance our ability to apply these systems more
generally.
CONCLUSION
The ability to use CRISPR/Cas9 systems for genome en-
gineering in Drosophila and its cell lines will revolutionise
genetic analysis by providing a targeted mutagen, which is
ideally suited to a relatively small genome size. The simplicity
at which it can be reprogrammed to target different sites will
also enable large-scale application of this technology genome-
wide, to allow more powerful reverse genetic analyses, and
allow us to more easily study combinations of mutations.
A simpler method of homologous targeting will also enable
wider application of defined modifications of the genome to
study the importance of genomic regions. This can be used to
make more appropriate tools for visualisation, detection and
purification of proteins. Importantly, this will allow detailed
analysis of gene function that would not be visible in simple
genetic knockouts, and permit studies of the vast expanse of
non-coding sequence.
The plethora of other techniques that use the sequence
specific binding ability of Cas proteins to recruit other protein
domains or RNA moieties offers a wealth of resources to
manipulate transcriptional, epigenetic or topological features
of chromatin. This will enable more delicate manipulations of
many cellular functions, and the array of techniques available
will no doubt be expanded in the future.
Genome editing will change the way in which we think
about and perform genetic and genomic analysis. Combined
with the power of genetic screens to identify phenotypes or
modify existing ones, and the powerful developmental genetic
tools and reagents already available, it will keep the humble
fruit fly to the forefront of genetics for many years to come.
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